Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ira Gewolb, M.D.
University of Maryland, Baltimore
Principal Investigator - Jonathan M Davis, MD
Dept of pediatrics, Winthrop University Hospital, SUNY Stony Brook School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Christiana Healthcare Systems
Wilmington, Delaware, United States
- Mercy Medical Center
Baltimore, Maryland, United States
- University of Maryland School of Medicine
Baltimore, Maryland, United States
- Winthrop-University Hospital, Suny Stony Brook School of Medicine
Mineola, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2000
- Primary completion
- 30 Jun 2002
- Completion
- 31 Dec 2003
- Last update posted
- 17 Nov 2011
- Registered enrollment
- 22
- Registry id
- NCT01473264
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.